Charles Schwab’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Buy |
|
|||||
|
2025
Q1 | $6.86M | Sell |
|
|||||
|
2024
Q4 | $5.73M | Buy |
|
|||||
|
2024
Q3 | $4.69M | Buy |
|
|||||
|
2024
Q2 | $3.28M | Buy |
|
|||||
|
2024
Q1 | $2.79M | Buy |
|
|||||
|
2023
Q4 | $3.7M | Sell |
|
|||||
|
2023
Q3 | $4.68M | Buy |
|
|||||
|
2023
Q2 | $5.62M | Buy |
|
|||||
|
2023
Q1 | $7.27M | Sell |
|
|||||
|
2022
Q4 | $6.3M | Buy |
|
|||||
|
2022
Q3 | $5.68M | Sell |
|
|||||
|
2022
Q2 | $8.85M | Buy |
|
|||||
|
2022
Q1 | $11.9M | Buy |
|
|||||
|
2021
Q4 | $23.6M | Buy |
|
|||||
|
2021
Q3 | $27.9M | Buy |
|
|||||
|
2021
Q2 | $25.6M | Buy |
|
|||||
|
2021
Q1 | $24.3M | Buy |
|
|||||
|
2020
Q4 | $32.6M | Buy |
|
|||||
|
2020
Q3 | $26.3M | Buy |
|
|||||
|
2020
Q2 | $7.67M | Buy |
|
|||||
|
2020
Q1 | $4.07M | Buy |
|
|||||
|
2019
Q4 | $2.75M | Buy |
|
|||||
|
2019
Q3 | $2.79M | Buy |
|